Metabolic syndrome

• 

  Subject Areas on Research

  • A 2-Year Holistic Health and Stress Intervention: Results of an RCT in Clergy. 
  • A Structural Model of Social Determinants of the Metabolic Syndrome. 
  • A genome-wide association study reveals a quantitative trait locus of adiponectin on CDH13 that predicts cardiometabolic outcomes. 
  • A lifestyle intervention of weight loss via a low-carbohydrate diet plus walking to reduce metabolic disturbances caused by androgen deprivation therapy among prostate cancer patients: carbohydrate and prostate study 1 (CAPS1) randomized controlled trial. 
  • A path model of chronic stress, the metabolic syndrome, and coronary heart disease. 
  • AKT1 polymorphisms are associated with risk for metabolic syndrome. 
  • Actual 10-Year Survivors After Resection of Hepatocellular Carcinoma. 
  • Air pollution, residential greenness, and metabolic dysfunction biomarkers: analyses in the Chinese Longitudinal Healthy Longevity Survey. 
  • Androgen-deprivation therapy and metabolic syndrome in men with prostate cancer. 
  • Angiotensin Receptor Blockade Improves Cardiac Surgical Outcomes in Patients With Metabolic Syndrome. 
  • Ankyrin-B metabolic syndrome combines age-dependent adiposity with pancreatic β cell insufficiency. 
  • Apolipoprotein E knock-out and knock-in mice: atherosclerosis, metabolic syndrome, and beyond. 
  • Application of combined omics platforms to accelerate biomedical discovery in diabesity. 
  • Are stress eaters at risk for the metabolic syndrome? 
  • Are there differences in symptoms experienced by midlife climacteric women with and without metabolic syndrome? A scoping review. 
  • Association between Bout Duration of Physical Activity and Health: Systematic Review. 
  • Association between adult and childhood socioeconomic status and prevalence of the metabolic syndrome in African Americans: the Pitt County Study. 
  • Association between metabolic syndrome, radiographic knee osteoarthritis, and intensity of knee pain: results of a national survey. 
  • Association of C-reactive protein and metabolic syndrome in a rural Chinese population. 
  • Association of HIV serostatus and metabolic syndrome with neurobehavioral disturbances. 
  • Association of HIV-infection, antiretroviral treatment and metabolic syndrome with large artery stiffness: a cross-sectional study. 
  • Association of Metabolic Phenotypes With Coronary Artery Disease and Cardiovascular Events in Patients With Stable Chest Pain. 
  • Association of PM_2.5 and Its Chemical Compositions with Metabolic Syndrome: A Nationwide Study in Middle-Aged and Older Chinese Adults. 
  • Association of cortisol and the metabolic syndrome in Korean men and women. 
  • Association of metabolic syndrome and its individual components with outcomes among patients with high-risk non-ST-segment elevation acute coronary syndromes. 
  • Associations between metabolic syndrome and syndrome components and retinal microvascular signs in a rural Chinese population: the Handan Eye Study. 
  • Associations of intergenerational education with metabolic health in U.S. Latinos. 
  • Bariatric surgery as a means to decrease mortality in women with type I endometrial cancer - An intriguing option in a population at risk for dying of complications of metabolic syndrome. 
  • Baroreflex Impairment Precedes Cardiometabolic Dysfunction in an Experimental Model of Metabolic Syndrome: Role of Inflammation and Oxidative Stress. 
  • Benefits of potassium intake on metabolic syndrome: The fourth Korean National Health and Nutrition Examination Survey (KNHANES IV). 
  • Branched chain amino acids are novel biomarkers for discrimination of metabolic wellness. 
  • COMT Val158Met Polymorphism, Cardiometabolic Risk, and Nadir CD4 Synergistically Increase Risk of Neurocognitive Impairment in Men Living With HIV. 
  • Cafeteria diet is a robust model of human metabolic syndrome with liver and adipose inflammation: comparison to high-fat diet. 
  • Cardiometabolic Health in Submariners Returning from a 3-Month Patrol. 
  • Cardiovascular disease risk stratification with stress single-photon emission computed tomography technetium-99m tetrofosmin imaging in patients with the metabolic syndrome and diabetes mellitus. 
  • Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment. 
  • Caspase-2 promotes obesity, the metabolic syndrome and nonalcoholic fatty liver disease. 
  • Catastrophic stroke burden in a patient with uncontrolled psoriasis and psoriatic arthritis: a case report. 
  • Central corneal thickness and its associations with ocular and systemic factors: the Singapore Malay Eye Study. 
  • Central nervous system serotonin and clustering of hostility, psychosocial, metabolic, and cardiovascular endophenotypes in men. 
  • Characteristics and Correlates of Metabolic Syndrome in Adolescents with Unipolar and Bipolar Depression: Results from a Cross-National Inpatient Case-Control Study. 
  • Chronic exposure to air pollution particles increases the risk of obesity and metabolic syndrome: findings from a natural experiment in Beijing. 
  • Comment on: Risk prediction of complications of metabolic syndrome before and 6 years after gastric bypass. 
  • Comorbidities in the first 2 years after arthroscopic hip surgery: substantial increases in mental health disorders, chronic pain, substance abuse and cardiometabolic conditions. 
  • Comorbidity screening in hidradenitis suppurativa: Evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations. 
  • Comparison of aerobic versus resistance exercise training effects on metabolic syndrome (from the Studies of a Targeted Risk Reduction Intervention Through Defined Exercise - STRRIDE-AT/RT). 
  • Contribution of adipogenesis to healthy adipose tissue expansion in obesity. 
  • Coronary artery disease epidemic in Pakistan: more electrocardiographic evidence of ischaemia in women than in men. 
  • Correlation between pericardial, mediastinal, and intrathoracic fat volumes with the presence and severity of coronary artery disease, metabolic syndrome, and cardiac risk factors. 
  • Costs of the metabolic syndrome in elderly individuals: findings from the Cardiovascular Health Study. 
  • Cytokines and the pathogenesis of non-alcoholic steatohepatitis. 
  • Depression as a risk factor for coronary artery disease: evidence, mechanisms, and treatment. 
  • Detection of genetic loci associated with plasma fetuin-A: a meta-analysis of genome-wide association studies from the CHARGE Consortium. 
  • Diabetes, metabolic abnormalities, and glaucoma. 
  • Diabetes, metabolic comorbidities, and risk of hepatocellular carcinoma: Results from two prospective cohort studies. 
  • Diabetes-related knowledge, atherosclerotic risk factor control, and outcomes in acute coronary syndromes. 
  • Dietary patterns and the metabolic syndrome in obese and non-obese Framingham women. 
  • Discordances between predicted and actual risk in obese patients with suspected cardiac ischaemia. 
  • Does lipopolysaccharide-mediated inflammation have a role in OA? 
  • Dysfunction of inflammation-resolving pathways is associated with exaggerated postoperative cognitive decline in a rat model of the metabolic syndrome. 
  • Effect of voluntary exercise on peripheral tissue glucocorticoid receptor content and the expression and activity of 11beta-HSD1 in the Syrian hamster. 
  • Effects of PREMIER lifestyle modifications on participants with and without the metabolic syndrome. 
  • Effects of combination lipid therapy on coronary stenosis progression and clinical cardiovascular events in coronary disease patients with metabolic syndrome: a combined analysis of the Familial Atherosclerosis Treatment Study (FATS), the HDL-Atherosclerosis Treatment Study (HATS), and the Armed Forces Regression Study (AFREGS). 
  • Effects of exercise and weight loss on cardiac risk factors associated with syndrome X. 
  • Effects of low-carbohydrate diets versus low-fat diets on metabolic risk factors: a meta-analysis of randomized controlled clinical trials. 
  • Effects of switching from olanzapine, quetiapine, and risperidone to aripiprazole on 10-year coronary heart disease risk and metabolic syndrome status: results from a randomized controlled trial. 
  • Epicardial adipose tissue and metabolic syndrome: An update protocol for systematic review and meta-analysis. 
  • Epigenome-wide association study of metabolic syndrome in African-American adults. 
  • Ethnic variation in the impact of metabolic syndrome components and chronic kidney disease. 
  • Evaluating the association of social needs assessment data with cardiometabolic health status in a federally qualified community health center patient population. 
  • Evaluation of the risk factors associated with rectal neuroendocrine tumors: a big data analytic study from a health screening center. 
  • Evidence for substantial effect modification by gender in a large-scale genetic association study of the metabolic syndrome among coronary heart disease patients. 
  • Exercise training amount and intensity effects on metabolic syndrome (from Studies of a Targeted Risk Reduction Intervention through Defined Exercise). 
  • Exercise training increases electron and substrate shuttling proteins in muscle of overweight men and women with the metabolic syndrome. 
  • Extended-release niacin therapy and risk of ischemic stroke in patients with cardiovascular disease: the Atherothrombosis Intervention in Metabolic Syndrome with low HDL/High Triglycerides: Impact on Global Health Outcome (AIM-HIGH) trial. 
  • Faecal microbiota transplantation from metabolically compromised human donors accelerates osteoarthritis in mice. 
  • Fatty liver, hypertension, and the metabolic syndrome. 
  • Features of the metabolic syndrome and prostate cancer in African-American men. 
  • Frequency, Regional Variation, and Predictors of Undetermined Cause of Death in Cardiometabolic Clinical Trials: A Pooled Analysis of 9259 Deaths in 9 Trials. 
  • Fructose consumption as a risk factor for non-alcoholic fatty liver disease. 
  • Fructose metabolism and metabolic disease. 
  • Gene by sex interaction in the etiology of coronary heart disease and the preceding metabolic syndrome. 
  • Gene by stress genome-wide interaction analysis and path analysis identify EBF1 as a cardiovascular and metabolic risk gene. 
  • General medical burden in bipolar disorder: findings from the LiTMUS comparative effectiveness trial. 
  • Gout, hyperuricemia, and the risk of cardiovascular disease: cause and effect? 
  • Health Behavior Profiles Among Midlife Women: Identifying At-Risk Subgroups for Metabolic Syndrome Using Latent Class Analysis. 
  • Heart and kidneys: sharing more than just blood. 
  • Heart disease and stroke statistics--2011 update: a report from the American Heart Association. 
  • Hepatic Mitochondrial SAB Deletion or Knockdown Alleviates Diet-Induced Metabolic Syndrome, Steatohepatitis, and Hepatic Fibrosis. 
  • High-Intensity Interval Training for Cardiometabolic Disease Prevention. 
  • High-density lipoprotein-cholesterol functionality and metabolic syndrome: Protocol for review and meta-analysis. 
  • How Common is Subsequent Posterior Tibial Tendon Dysfunction or Tarsal Tunnel Syndrome After Ankle Sprain Injury? 
  • Hypertension, obesity and prostate cancer biochemical recurrence after radical prostatectomy. 
  • Identification of Symptom Clusters Among Midlife Menopausal Women with Metabolic Syndrome. 
  • Identification of high-risk symptom cluster burden group among midlife peri-menopausal and post-menopausal women with metabolic syndrome using latent class growth analysis. 
  • Impact of baseline physical activity and diet behavior on metabolic syndrome in a pharmaceutical trial: results from NAVIGATOR. 
  • Impact of lung-function measures on cardiovascular disease events in older adults with metabolic syndrome and diabetes. 
  • In-Hospital Mortality and Post-Surgical Complications Among Cancer Patients with Metabolic Syndrome. 
  • Incidental findings on cardiac multidetector row computed tomography among healthy older adults: prevalence and clinical correlates. 
  • Increased subclinical atherosclerosis in young adults with metabolic syndrome: the Bogalusa Heart Study. 
  • Influence of change in aerobic fitness and weight on prevalence of metabolic syndrome. 
  • Inhibition of the gut enzyme intestinal alkaline phosphatase may explain how aspartame promotes glucose intolerance and obesity in mice. 
  • Insulin resistance syndrome and nonalcoholic fatty liver disease. 
  • Insurance coverage and incentives for weight loss among adults with metabolic syndrome. 
  • Intestinal alkaline phosphatase prevents metabolic syndrome in mice. 
  • LV Mass as a Predictor of CVD Events in Older Adults With and Without Metabolic Syndrome and Diabetes. 
  • Letter to the Editor: Posttraumatic stress disorder has genetic overlap with cardiometabolic traits. 
  • Long-Term Effectiveness of a Lifestyle Intervention: A Pragmatic Community Trial to Prevent Metabolic Syndrome. 
  • Long-Term Safety and Efficacy of Durable Polymer Cobalt-Chromium Everolimus-Eluting Stents in Patients at High Bleeding Risk: A Patient-Level Stratified Analysis From Four Postapproval Studies. 
  • Long-term efficacy and safety of ezetimibe/simvastatin coadministered with extended-release niacin in hyperlipidaemic patients with diabetes or metabolic syndrome. 
  • Low Carbohydrate Diets and Estimated Cardiovascular and Metabolic Syndrome Risk in Prostate Cancer. 
  • Low birth weight is associated with components of the metabolic syndrome. 
  • Management of adolescents with polycystic ovary syndrome. 
  • Maternal pre-pregnancy obesity, offspring cord blood DNA methylation, and offspring cardiometabolic health in early childhood: an epigenome-wide association study. 
  • Metabolic Syndrome Among Antiretroviral Therapy-Naive Versus Experienced HIV-Infected Patients Without Preexisting Cardiometabolic Disorders in Western Kenya. 
  • Metabolic Syndrome Negatively Impacts Stone-Specific Quality of Life. 
  • Metabolic Syndrome Prevalence by Race/Ethnicity and Sex in the United States, National Health and Nutrition Examination Survey, 1988-2012. 
  • Metabolic Syndrome and Associated Diseases: From the Bench to the Clinic. 
  • Metabolic Syndrome and Neurocognitive Deficits in HIV Infection. 
  • Metabolic Syndrome and Risk of Breast Cancer by Molecular Subtype: Analysis of the MEND Study. 
  • Metabolic Syndrome and the Lung. 
  • Metabolic dysregulation and cancer mortality in a national cohort of blacks and whites. 
  • Metabolic effects associated with atypical antipsychotic treatment in the developmentally disabled. 
  • Metabolic inflexibility: when mitochondrial indecision leads to metabolic gridlock. 
  • Metabolic syndrome and eye diseases. 
  • Metabolic syndrome and in-hospital outcomes among pancreatic cancer patients. 
  • Metabolic syndrome and liver steatosis occur at lower body mass index in US Asian patients with chronic hepatitis B. 
  • Metabolic syndrome and mortality in the elderly: a time-dependent association. 
  • Metabolic syndrome and risk of age-related cataract over time: an analysis of interval-censored data using a random-effects model. 
  • Metabolic syndrome and risk of age-related macular degeneration. 
  • Metabolic syndrome and risk of breast cancer mortality by menopause, obesity, and subtype. 
  • Metabolic syndrome and risk of stroke: Protocol for an update systematic review and meta-analysis. 
  • Metabolic syndrome components and age-related cataract: the Singapore Malay eye study. 
  • Metabolic syndrome is associated with aggressive prostate cancer regardless of race. 
  • Metabolic syndrome predicts mobility decline in a community-based sample of older adults. 
  • Metabolic syndrome, C-reactive protein, and prognosis in patients with established coronary artery disease. 
  • Metabolic syndrome, diabetes mellitus, or both and cardiovascular risk in outpatients with or at risk for atherothrombosis. 
  • Metabolic syndrome-like components and prostate cancer risk: results from the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) study. 
  • Metabolic syndrome. 
  • Metabolic syndrome: definition, pathophysiology, and mechanisms. 
  • Metabolic syndrome: evaluation of pathological and therapeutic outcomes. 
  • Metabolomic profiling reveals mitochondrial-derived lipid biomarkers that drive obesity-associated inflammation. 
  • Minimal versus umbilical waist circumference measures as indicators of cardiovascular disease risk. 
  • Multimarker approach to evaluate the incidence of the metabolic syndrome and longitudinal changes in metabolic risk factors: the Framingham Offspring Study. 
  • NAFLD, NASH and liver cancer. 
  • Nonalcoholic steatohepatitis and nonalcoholic Fatty liver disease in young women with polycystic ovary syndrome. 
  • Number of children and risk of metabolic syndrome in women. 
  • Nutritional risk and the metabolic syndrome in women: opportunities for preventive intervention from the Framingham Nutrition Study. 
  • Obesity among those with mental disorders: a National Institute of Mental Health meeting report. 
  • Obesity and metabolic stone disease. 
  • Obesity and synergistic risk factors for chronic kidney disease in African American adults: the Jackson Heart Study. 
  • Performance of a weight-related measure of Quality of Life in a psychiatric sample. 
  • Periodontitis and multiple markers of cardiometabolic risk in the fourth decade: A cohort study. 
  • Phosphodiesterase 5 inhibition improves beta-cell function in metabolic syndrome. 
  • Physical activity attenuated the associations between ambient air pollutants and metabolic syndrome (MetS): A nationwide study across 28 provinces. 
  • Pigment epithelium-derived factor (PEDF) suppresses IL-1β-mediated c-Jun N-terminal kinase (JNK) activation to improve hepatocyte insulin signaling. 
  • Plasma lactate as a marker of metabolic health: Implications of elevated lactate for impairment of aerobic metabolism in the metabolic syndrome. 
  • Polycystic ovary syndrome and severe nonalcoholic steatohepatitis: beneficial effect of modest weight loss and exercise on liver biopsy findings. 
  • Prevalence and Associations of Metabolic Syndrome in an Urban High Diabetes Risk Population in a Low/Middle-Income Country. 
  • Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III. 
  • Prevention of antibiotic-associated metabolic syndrome in mice by intestinal alkaline phosphatase. 
  • Prolactin-related and metabolic adverse effects of atypical antipsychotic agents. 
  • Prospective Associations Between Depressive Symptoms and the Metabolic Syndrome: the Spirited Life Study of Methodist Pastors in North Carolina. 
  • Refocusing the AIM on HDL in the metabolic syndrome. 
  • Regulator of Calcineurin 1 helps coordinate whole-body metabolism and thermogenesis. 
  • Relation of the Metabolic Syndrome to Incident Colorectal Cancer in Young Adults Aged 20 to 49 Years. 
  • Relationship between obesity severity, metabolic status and cardiovascular disease in obese adults. 
  • Relationship of lipoproteins to cardiovascular events: the AIM-HIGH Trial (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglycerides and Impact on Global Health Outcomes). 
  • Relationships between metabolic syndrome and other baseline factors and the efficacy of ezetimibe/simvastatin and atorvastatin in patients with type 2 diabetes and hypercholesterolemia. 
  • Response to: Khusid, Atallah, and Gupta re: "Metabolic Syndrome Negatively Impacts Stone-Specific Quality of Life" by Lim et al. 
  • Retinal vascular manifestations of metabolic disorders. 
  • Retinal vasculature and 5-year metabolic syndrome among women with gestational diabetes mellitus. 
  • Risk of stroke and cardiovascular events after ischemic stroke or transient ischemic attack in patients with type 2 diabetes or metabolic syndrome: secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. 
  • Role of inflammation in nonalcoholic steatohepatitis. 
  • SIRT3 deficiency and mitochondrial protein hyperacetylation accelerate the development of the metabolic syndrome. 
  • SIRT3 weighs heavily in the metabolic balance: a new role for SIRT3 in metabolic syndrome. 
  • Sex hormone-binding globulin, but not testosterone, is associated prospectively and independently with incident metabolic syndrome in men: the framingham heart study. 
  • Should nonalcoholic fatty liver disease be treated differently in elderly patients? 
  • Skeletal muscle dictates the fibrinolytic state after exercise training in overweight men with characteristics of metabolic syndrome. 
  • Surgery results in exaggerated and persistent cognitive decline in a rat model of the Metabolic Syndrome. 
  • Symptom Clusters and Key Symptoms Among Midlife Perimenopausal and Postmenopausal Women With and Without Metabolic Syndrome. 
  • The Association of Stress, Metabolic Syndrome, and Systemic Inflammation With Neurocognitive Function in the Hispanic Community Health Study/Study of Latinos and Its Sociocultural Ancillary Study. 
  • The Clinical Antipsychotic Trials Of Intervention Effectiveness (CATIE) Schizophrenia Trial: clinical comparison of subgroups with and without the metabolic syndrome. 
  • The Metabolic Syndrome and Risk of Sudden Cardiac Death: The Atherosclerosis Risk in Communities Study. 
  • The Metabolic Syndrome in Children and Adolescents: Shifting the Focus to Cardiometabolic Risk Factor Clustering. 
  • The conundrum of cryptogenic cirrhosis: Adverse outcomes without treatment options. 
  • The differential effects of angiotensin II type 1 receptor blockers on microalbuminuria in relation to low-grade inflammation in metabolic hypertensive patients. 
  • The effect of gemfibrozil, niacin and cholestyramine combination therapy on metabolic syndrome in the Armed Forces Regression Study. 
  • The metabolic syndrome and retinal microvascular signs in a Japanese population: the Funagata study. 
  • The metabolic syndrome, coronary artery calcium score and cardiovascular risk reclassification. 
  • The relationship between the blood pressure responses to exercise following training and detraining periods. 
  • Trends in glyburide compared with insulin use for gestational diabetes treatment in the United States, 2000-2011. 
  • Trends in the prevalence of metabolic syndrome and its components in the United States 2007-2014. 
  • Use of a randomized multiple baseline design: rationale and design of the spirited life holistic health intervention study. 
  • Vascular risk factors and cognitive decline among elderly male twins. 
  • Walking in old age and development of metabolic syndrome: the health, aging, and body composition study. 
  • Zac1 and the Imprinted Gene Network program juvenile NAFLD in response to maternal metabolic syndrome. 
  • [Anti-hypertensive treatment in metabolic syndrome--focus on ARB or ACE inhibitor]. 
  • [Most recommended timing to start medication for hypertensive patients]. 
  • [The clinical utility of angiotensin receptor blockers in out-of-office hypertension (masked hypertension, workplace hypertension, and home hypertension)].